Current Practices in Ocular Toxoplasmosis: A Survey of Brazilian Uveitis Specialists

Página do item simplificado
dc.citation.issue2
dc.citation.volume26
dc.contributor.authorMorais, Fabio Barreto [UNIFESP]
dc.contributor.authorFaria e Arantes, Tiago Eugenio
dc.contributor.authorMuccioli, Cristina [UNIFESP]
dc.coveragePhiladelphia
dc.date.accessioned2020-07-02T18:52:02Z
dc.date.available2020-07-02T18:52:02Z
dc.date.issued2018
dc.description.abstractPurpose: To describe treatment practices for ocular toxoplasmosis among members of the Brazilian Uveitis Society.Methods: An online questionnaire sent to specialists, between October 2014 and March 2015.Results: Most respondents (67.9%) treat all active cases. Most specialists consider visual acuity <20/200 (88.2%), severe vitreous inflammation (94.1%), and ocular disease during acquired infection (88.2%) as absolute indications for treatment. Systemic steroids are associated with anti-toxoplasmic therapy in most cases by 50.9% of the respondents. For immunocompetent individuals, 57.4% of the respondents chose trimethoprim/sulfamethoxazole. Classical therapy (sulfadiazine/pyrimethamine) is preferred most for patients with central lesions (70.4%), immunosuppression (68.4%), acquired infection (70.4%), and atypical forms (74.1%). For patients with frequent relapses, 84.9% of the respondents preferred antibiotic prophylaxis.Conclusions: Treatment patterns of ocular toxoplasmosis are not uniform among Brazilian specialists. Most specialists treat all cases of active retinochoroiditis. Typical cases are more frequently treated with trimethoprim/sulfamethoxazole. However, classical therapy is the regimen of choice when lesions are considered more severe.en
dc.description.affiliationUniv Fed Sao Paulo UNIFESP, Dept Ophthalmol, Sao Paulo, SP, Brazil
dc.description.affiliationFundacao Altino Ventura, Recife, PE, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo UNIFESP, Dept Ophthalmol, Sao Paulo, SP, Brazil
dc.description.sourceWeb of Science
dc.format.extent317-323
dc.identifierhttp://dx.doi.org/10.1080/09273948.2016.1215471
dc.identifier.citationOcular Immunology And Inflammation. Philadelphia, v. 26, n. 2, p. 317-323, 2018.
dc.identifier.doi10.1080/09273948.2016.1215471
dc.identifier.issn0927-3948
dc.identifier.urihttps://repositorio.unifesp.br/handle/11600/53840
dc.identifier.wosWOS:000426938900029
dc.language.isoeng
dc.publisherTaylor & Francis Inc
dc.relation.ispartofOcular Immunology And Inflammation
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectAntibioticsen
dc.subjectocular toxoplasmosisen
dc.subjectpracticesen
dc.subjectspecialistsen
dc.subjectsurveyen
dc.subjecttreatmenten
dc.subjectuveitisen
dc.titleCurrent Practices in Ocular Toxoplasmosis: A Survey of Brazilian Uveitis Specialistsen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
EPM - Artigos